Oguntade Habibat A, Grubin Fiona, Foster Hanna, Tessay Robin, Neault Nicole, Mitchell Kristin, Masten Kristin, Sundbo Anna, Rosenstock Summer, Sutcliffe Catherine G, Hammitt Laura L, Barlow Allison, Cwik Mary
Johns Hopkins Center for Indigenous Health, Baltimore, MD, USA.
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
J Racial Ethn Health Disparities. 2025 Aug 22. doi: 10.1007/s40615-025-02598-0.
The COVID-19 pandemic highlighted longstanding health inequities, particularly among American Indian/Alaska Native (AIAN) communities, which experienced disproportionately high morbidity and mortality. This manuscript documents the implementation, adaptation, and lessons learned from a randomized controlled trial (RCT) conducted during a rapidly evolving pandemic context. The RCT tested two public health interventions: (1) a motivational interviewing strategy to promote COVID-19 testing and preventive behaviors, and (2) a symptom monitoring tool to assess COVID-related symptoms. As the public health landscape shifted with the introduction of vaccines and evolving guidance, protocols required frequent adaptation to remain relevant. Four major amendments were made to adapt the study to evolving conditions, including changes to inclusion criteria, the addition of community-prioritized content such as vaccine hesitancy, and adjustments to accommodate mixed vaccination statuses within households. Delays in multiple IRB approvals often rendered changes outdated by the time they could be implemented. Recruitment was limited, and intervention delivery faced challenges including low survey completion and technological barriers. Nonetheless, strong collaboration with tribal partners and respect for tribal sovereignty enabled culturally grounded, community-responsive adaptations throughout the study. Lessons from the implementation process underscore the need for flexible, adaptive research approaches that maintain rigorous community and tribal oversight. Future research on urgent, ongoing health issues can be strengthened through streamlined regulatory pathways and sustained partnerships with AIAN communities in future emergencies like the COVID-19 pandemic. ClinicalTrials.gov Identifier: NCT04765475.
新冠疫情凸显了长期存在的健康不平等问题,尤其是在美国印第安人/阿拉斯加原住民(AIAN)社区,这些社区的发病率和死亡率高得不成比例。本手稿记录了在迅速演变的疫情背景下进行的一项随机对照试验(RCT)的实施、调整情况以及经验教训。该随机对照试验测试了两种公共卫生干预措施:(1)一种动机性访谈策略,以促进新冠病毒检测和预防行为;(2)一种症状监测工具,用于评估与新冠相关的症状。随着疫苗的推出和指导意见的不断演变,公共卫生形势发生了变化,方案需要频繁调整以保持相关性。为使研究适应不断变化的情况,进行了四项主要修订,包括更改纳入标准、增加社区优先关注的内容(如疫苗犹豫),以及调整以适应家庭内不同的疫苗接种状况。多个机构审查委员会(IRB)批准的延迟往往导致更改在实施时就已过时。招募工作受到限制,干预措施的实施面临挑战,包括调查完成率低和技术障碍。尽管如此,与部落伙伴的紧密合作以及对部落主权的尊重使得在整个研究过程中能够进行基于文化、响应社区需求的调整。实施过程中的经验教训强调了需要采用灵活、适应性强的研究方法,同时保持严格的社区和部落监督。未来针对紧迫、持续的健康问题的研究可以通过简化监管途径以及在未来类似新冠疫情这样的紧急情况下与AIAN社区保持持续伙伴关系来得到加强。临床试验.gov标识符:NCT04765475。